Elizabeth Ansert, DPM
Podiatrist · Thibodaux, LANPI 1295295145
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.0%), education and other — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Stryker at 49.3% of the total. 2025 is the largest year on record at $1,804, more than ten times the $32 reported in 2021.
Across 71 payments — averaging $83.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Integra Lifesciences Corporation$1K
- Kairos Surgical Inc$1K
- Nevro Corp.$149
- ALON Medical Technology$83
- Polynovo North America LLC$61
- plus $136 from 5 others
What the payments were for
- Travel & lodging$5449%
- Food & beverage$3,38357%
- Education$1,20020%
- Other$80714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 50 | $2,926 |
| Integra Lifesciences Corporation | 7 | $1,363 |
| Kairos Surgical Inc | 2 | $1,216 |
| Nevro Corp. | 1 | $149 |
| ALON Medical Technology | 2 | $83 |
| Polynovo North America LLC | 2 | $61 |
| Life Spine, Inc. | 1 | $34 |
| Kuros Biosciences USA, Inc | 2 | $34 |
| Smith+Nephew | 2 | $32 |
| Convatec Inc. | 1 | $22 |
| Vertex | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,872
- INTEGRA DERMAL REGENERATION TEMPLATE$519
- PRIMATRIX$519
- ORTHOLOC 2 LAPIFUSE$480
- 7 X 23MM CITRELOCK IMPLANT$296
- ACell$245
- MICROMATRIX$245
- ASNIS$169
- BIOskin$168
- CITREFIX$168
- CHARLOTTE$149
- Senza$149
- PROSTEP MICA$115
- PRIME SERIES$113
How this compares
$5,933 in reported general payments places this provider in the 70th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amitriptyline Hcl | 22 | $201 |
| Cephalexin | 24 | $106 |
| Gabapentin | 19 | $102 |
| Methylprednisolone | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Thibodaux
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
- Rustin AjdariSlidell$15K
- Oghale EleyaeNatchitoches$12K
- Rory PanepintoMetairie$12K
- John CarradineMetairie$11K
- John DestefanoFort Polk$10K
- Nneka MekaNew Orleans$9K
- Robert MarroquinMetairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.